Companies Mentioned
Why It Matters
By turning unstructured, unverified documents into auditable, AI‑ready data, Transform 2026.1 reduces hallucinations, compliance failures and costly manual work, unlocking scalable AI value for regulated enterprises.
Key Takeaways
- •AI Model Builder creates extraction models from samples in minutes, not weeks
- •Object Separation boosts visual element extraction accuracy by 20%
- •Source citations link AI answers to original documents for audit trails
- •MS Exchange connector removes manual email triage for insurance claim intake
- •Open Source LLM support eliminates external token costs for regulated AI
Pulse Analysis
Regulated industries such as life sciences and insurance have poured billions into AI platforms, yet the real obstacle lies in the quality of source documents. Inconsistent, incomplete or untraceable files cause model hallucinations, claim rejections and audit failures, forcing firms to spend valuable resources on manual remediation. Transform 2026.1 tackles this head‑on by embedding validation, provenance and human oversight directly into the document ingestion pipeline, turning raw data into a trustworthy foundation for any large‑language model.
The platform’s five core capabilities address the most painful pain points. The AI Model Builder lets data teams configure extraction models in minutes, slashing deployment cycles from weeks to hours. Object Separation parses multi‑modal files—CAD drawings, tables, images—improving visual extraction accuracy by roughly 20%. Source‑cited AI chat provides a clickable audit trail for every generated answer, while the HITL classification trigger records every human correction for GxP compliance. Large‑document stitching ensures that multi‑hundred‑page regulatory filings are processed without slowdown, and the new connectors (Veeva Vault, MS Exchange, M‑Files, SharePoint) automate capture from existing enterprise repositories.
For enterprises, the impact translates into measurable cost savings and risk reduction. Insurance carriers can eliminate up to $100K per year in third‑party token expenses, and life‑sciences firms gain defensible evidence for FDA or EMA submissions. By offering on‑prem, cloud or hybrid deployment and supporting Open‑Source LLMs, Adlib gives regulated organizations full control over data residency and security. As AI adoption accelerates, tools that guarantee data integrity and auditability—like Transform 2026.1—will become essential enablers of compliant, scalable AI across the enterprise.
Adlib releases Transform 2026.1 for regulated AI

Comments
Want to join the conversation?
Loading comments...